Eileen tracks developments in OTC drug research, manufacturing, regulation, finance, M&A and marketing. She favors stories on e-commerce trends and the industry's drive toward Rx-to-OTC drug switches. Eileen also contributes coverage on the dietary supplement industry. She has a keen eye for pieces that delve into the rising self-care movement and how it is raising the innovation bar for marketers.
Latest from Eileen Francis
The US Food and Drug Administration has released a roadmap to adopt new approach methodologies in lieu of animal testing for monoclonal antibody therapies and other drugs, which may include OTC drugs though the proposal does not specifically include cosmetics.
Coty’s ‘All-in to Win’ program enters the next phase, which sets aggressive savings over the next two years in part by simplifying and scaling its operating model, in addition to boosting its innovation impact.
The Procter & Gamble Company is working to mitigate the impact of tariffs, which will add up to $1.5bn in costs annually. The firm has lowered its fiscal 2025 outlook.
Plano, Texas-based Simpler Hair Color Inc. may face FTC enforcement action after it failed to comply with the National Advertising Division’s recommendations it discontinue the claim, “Rated #1 Men’s Hair Color,” associated with a consumer review website.
Beiersdorf AG hit some initial bumps with a repositioning of its business in China, but the firm is optimistic about the rollout of Thiamidol Skin Care In 2026.
Revlon Group Holdings LLC announces Dana Medema, formerly VP and head of Personal Health in North America for Philips, will serve as president, North America. Separately, Shiseido Company, Ltd. reports Ron Gee has resigned as Americas Region CEO and will be replaced on an interim basis by Alberto Noe.